Position in AZN
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$3,968,367
-$763,137 QoQ
Shares Held
20,928
-12.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#423
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 89%
Shared 0%
None 11%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HM PAYSON & CO holds $421,884,223 across 14 Drug Manufacturers - General names. AZN ranks #8 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
596,837 | $150,188,062 | |
| 2 | JNJ |
Johnson & Johnson
|
391,709 | $99,482,334 | |
| 3 | LLY |
ELI LILLY & Co
|
53,616 | $64,308,643 | |
| 4 | AMGN |
Amgen Inc
|
167,825 | $60,772,788 | |
| 5 | MRK |
Merck & Co., Inc.
|
172,406 | $22,154,171 | |
| 6 | PFE |
Pfizer Inc
|
453,303 | $10,915,536 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
113,175 | $6,521,142 | |
| 8 | AZN |
Astrazeneca PLC
This page
|
20,928 | $3,968,367 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,968,367 | 20,928 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $4,731,504 | 23,991 | Shares | Sole | 2026-04-13 | |
| No filing history on record for this holder in this stock. | ||||||